229 related articles for article (PubMed ID: 23918409)
1. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
J Pharm Sci; 2013 Oct; 102(10):3513-27. PubMed ID: 23918409
[TBL] [Abstract][Full Text] [Related]
2. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function.
Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
J Pharm Sci; 2014 Oct; 103(10):2963-79. PubMed ID: 25103275
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
4. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
Boner AL
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
[TBL] [Abstract][Full Text] [Related]
6. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
Wilson AM; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.
Zöllner EW
Pediatr Allergy Immunol; 2007 Sep; 18(6):469-74. PubMed ID: 17680905
[TBL] [Abstract][Full Text] [Related]
8. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
[TBL] [Abstract][Full Text] [Related]
9. [Adrenal effect of inhaled corticosteroids in adult asthmatic patients].
Adachi M; Minoguchi K
Nihon Kokyuki Gakkai Zasshi; 2006 Mar; 44(3):151-9. PubMed ID: 16617856
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.
Chrousos GP; Harris AG
Neuroimmunomodulation; 1998; 5(6):288-308. PubMed ID: 9762011
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 1. Which test should be used?
Zöllner EW
Pediatr Allergy Immunol; 2007 Aug; 18(5):401-9. PubMed ID: 17561933
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
13. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
[TBL] [Abstract][Full Text] [Related]
14. The hypothalamic-pituitary-adrenal axis in asthmatic children.
Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP
Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557
[TBL] [Abstract][Full Text] [Related]
15. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):501-10. PubMed ID: 1775677
[TBL] [Abstract][Full Text] [Related]
17. Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids.
Tsartsali L; Papadopoulos M; Lagona E; Papadimitriou A; Kanaka-Gantenbein C; Louizou E; Kastania A; Priftis KN; Chrousos G
Neuroimmunomodulation; 2012; 19(2):88-95. PubMed ID: 22248724
[TBL] [Abstract][Full Text] [Related]
18. Safety of the newer inhaled corticosteroids in childhood asthma.
Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Patel D; Ratner P; Clements D; Wu W; Faris M; Philpot E
Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
[TBL] [Abstract][Full Text] [Related]
20. Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers.
Bachert C; Lukat KF; Lange B
Clin Exp Allergy; 2004 Jan; 34(1):85-90. PubMed ID: 14720267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
